Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -35.71%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.12 per share when it actually produced a loss of $0.13, delivering a surprise of -8.33%.Over the last four q ...